Regulatory News NCI’s Letai, FDA’s Diamantas identify strategies to speed up cancer trialsLetai: 150 days to start a cancer trial is too long—cancer centers need to accept a little risk November 13, 2026Vol.52 No.42By Claire Marie Porter
Cancer Policy ACS CAN urges lawmakers to increase NCI funding in next appropriations bill November 13, 2026Vol.52 No.42By Sara Willa Ernst
In Brief Color Health collaborates with eight NCI-designated cancer centers to cut specialist wait times November 13, 2026Vol.52 No.42
Sponsored Community sites have the patients to boost trial enrollment—but not the infrastructure November 06, 2026Vol.52 No.41By Gordon Harris
Clinical Roundup CRC incidence rates are rising among all age groups, SEER data analysis finds November 06, 2026Vol.52 No.41
NCI NCI’s new CCSG is the result of “thousands of hours” of listening, negotiations, surprisesNew NOFO aims to shrink applications by 40% October 30, 2026Vol.52 No.40By Paul Goldberg
NCI NCAB ad hoc working group seeks to define its role as it approves eight reissue concepts“We could do a lot more than be another committee to check the RFAs before they go to the next level.” October 30, 2026Vol.52 No.40By Jacquelyn Cobb
In Brief Dinah Singer retires from NCI, remains at NIH as Scientist Emeritus October 30, 2026Vol.52 No.40
In Brief University of Illinois’ Andrei Gartel receives NCI grant to study AML October 30, 2026Vol.52 No.40